Archivos De La Sociedad Espanola De Oftalmologia最新文献

{"title":"Neuropatía óptica isquémica anterior no arterítica como única manifestación de una crisis hipertensiva maligna: presentación de un caso","authors":"","doi":"10.1016/j.oftal.2024.04.009","DOIUrl":"10.1016/j.oftal.2024.04.009","url":null,"abstract":"<div><div>Non-arteritic anterior ischemic optic neuropathy (NAION) is after glaucoma the most common optic neuropathy in patients over 50<!--> <!-->years. It is known that high blood pressure (HBP) is an important risk factor for the development of NAION. It is also known that malignant arterial hypertension (MAH) could be accompanied by optic disc edema. However, MAH has not classically been considered a cause of NAION. We report the case of a 32-year-old patient who presented irreversible visual loss with a pattern compatible with NAION as the only manifestation of a hypertensive crisis.</div></div>","PeriodicalId":8348,"journal":{"name":"Archivos De La Sociedad Espanola De Oftalmologia","volume":"99 10","pages":"Pages 450-454"},"PeriodicalIF":0.0,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141039880","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Efectividad de la válvula de Ahmed® implantada vía pars plana en pacientes con glaucoma refractario","authors":"","doi":"10.1016/j.oftal.2024.05.007","DOIUrl":"10.1016/j.oftal.2024.05.007","url":null,"abstract":"<div><h3>Purpose</h3><div>To evaluate the success rate and complications of the Ahmed® FP7 valve implanted via Pars Plana in a group of vitrectomized patients with refractory glaucoma and anterior segment abnormalities from January 2018 to June 2023.</div></div><div><h3>Methods</h3><div>Quasi-experimental, prospective study. Eleven eyes with refractory glaucoma were included. Participants underwent a comprehensive ophthalmic examination, including assessment of intraocular pressure (IOP) reduction, visual acuity, characterization of glaucoma type, and number of antiglaucoma medications.</div></div><div><h3>Results</h3><div>The mean baseline IOP was 37.3<!--> <!-->±<!--> <!-->11<!--> <!-->mmHg, which decreased to 13.5<!--> <!-->±<!--> <!-->3.0<!--> <!-->mmHg after one year. The qualified success rate was 63.7%, while the complete success rate was 36.3%. The most common diagnosis was neovascular glaucoma in 36.4% of cases. The most frequent postoperative complications were choroidal detachment and hypotony.</div></div><div><h3>Conclusions</h3><div>Our data suggest that implantation of the Ahmed FP7 valve via pars plana is an effective and safe option for patients with refractory secondary glaucoma.</div></div>","PeriodicalId":8348,"journal":{"name":"Archivos De La Sociedad Espanola De Oftalmologia","volume":"99 10","pages":"Pages 420-426"},"PeriodicalIF":0.0,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141391489","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Precisión de fórmulas para cálculo de LIO en pacientes con queratometrías promedio mayores de 46 dioptrías","authors":"","doi":"10.1016/j.oftal.2024.05.004","DOIUrl":"10.1016/j.oftal.2024.05.004","url":null,"abstract":"<div><h3>Objective</h3><div>To compare the accuracy of Kane, Barrett Universal<!--> <!-->II, Haigis, and SRK-T formulas in eyes with average keratometry greater than 46 diopters (D).</div></div><div><h3>Methods</h3><div>A retrospective analysis was conducted on 101 eyes of 101 patients with average keratometry greater than 46<!--> <!-->D. The absolute prediction error (EA) was obtained for each patient one month after surgery. The mean absolute prediction error (MEA), median absolute prediction error (MedEA) and the percentage of patients with absolute refractive error less than 0.25<!--> <!-->D, 0.50<!--> <!-->D, and 1.00<!--> <!-->D were calculated for each formula analyzed.</div></div><div><h3>Results</h3><div>The Kane formula achieved the lowest MEA (0.53<!--> <!-->±<!--> <!-->0.43) and the lowest MedEA (0.41), followed by Barrett Universal<!--> <!-->II (MEA: 0.56<!--> <!-->±<!--> <!-->0.42, MedEA: 0.49), SRK-T (MEA: 0.59<!--> <!-->±<!--> <!-->0.44, MedEA: 0.54), and Haigis (MEA: 0.77<!--> <!-->±<!--> <!-->0.47, MedEA: 0.69), showing a significant difference in the results. It was also observed that the Kane formula was the most accurate, with the highest percentage of patients, with EA less than 0.25<!--> <!-->D, 0.50<!--> <!-->D, and 1.00<!--> <!-->D (30.7%, 54.4%, and 86.1%, respectively), while the Haigis formula was the least accurate (12.9%, 33.7%, and 69.3%, respectively).</div></div><div><h3>Conclusion</h3><div>In eyes with corneas having average keratometry greater than 46<!--> <!-->D, the Kane formula proves to be a useful tool in intraocular lens (IOL) power calculation and demonstrates higher precision compared to the Barrett Universal<!--> <!-->II, SRK-T, and Haigis formulas.</div></div>","PeriodicalId":8348,"journal":{"name":"Archivos De La Sociedad Espanola De Oftalmologia","volume":"99 10","pages":"Pages 413-419"},"PeriodicalIF":0.0,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141397188","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Atrofia girata de la coroides y la retina: actualización en diagnóstico y tratamiento","authors":"","doi":"10.1016/j.oftal.2024.03.006","DOIUrl":"10.1016/j.oftal.2024.03.006","url":null,"abstract":"<div><p>Gyrate atrophy of the choroid and retina (GACR) is a rare autosomal recessive disease characterised by elevated plasma ornithine levels due to deficiency of the enzyme ornithine aminotransferase (OAT). The accumulation of this amino acid in plasma leads to the development of patches of chorioretinal atrophy in the peripheral retina extending into the macular area. Patients usually present with night blindness followed by constriction of the visual field and, finally, decreased central vision and blindness. The disease is diagnosed by the presence of the characteristic clinical picture, the presence of hyperornithinaemia in plasma and the detection of mutations in the OAT enzyme gene. There is currently no effective gene therapy and the most common therapeutic intervention mainly involves dietary modifications with arginine restriction.</p><p>This article aims to summarise the pathogenesis, clinical and diagnostic findings and treatment options in patients with GACR.</p></div>","PeriodicalId":8348,"journal":{"name":"Archivos De La Sociedad Espanola De Oftalmologia","volume":"99 9","pages":"Pages 392-399"},"PeriodicalIF":0.0,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140792129","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"El «ictus de la retina»: un llamado a la acción para la conciencia y el tratamiento de las emergencias vasculares oculares","authors":"","doi":"10.1016/j.oftal.2024.03.009","DOIUrl":"10.1016/j.oftal.2024.03.009","url":null,"abstract":"","PeriodicalId":8348,"journal":{"name":"Archivos De La Sociedad Espanola De Oftalmologia","volume":"99 9","pages":"Pages 363-364"},"PeriodicalIF":0.0,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140769093","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Mujer vigoréxica con pérdida severa bilateral de visión","authors":"","doi":"10.1016/j.oftal.2024.04.008","DOIUrl":"10.1016/j.oftal.2024.04.008","url":null,"abstract":"<div><p>We describe a 28-year-old Caucasian female with vigorexy, who had no previous ocular history. She presented with bilateral gradual painless reduction in vision over the past 3 weeks. She had been taking niacin supplements, averaging 500<!--> <!-->mg daily, for 7 years. Fundus examination revealed bilateral CME, which was confirmed by ocular coherence tomography scan. Fundus fluorescein angiography did not reveal any fluid leakage. Niacin supplementation was discontinued, and after 2 months, the CME had completely resolved, and the best corrected visual acuities improved to 1 in both eyes.</p></div>","PeriodicalId":8348,"journal":{"name":"Archivos De La Sociedad Espanola De Oftalmologia","volume":"99 9","pages":"Pages 408-411"},"PeriodicalIF":0.0,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141056384","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Bancos de ojos públicos de Andalucía: una década de mejora continua","authors":"M. Rodríguez-Calvo-de-Mora ,&nbsp;J. Giménez-Almenara-Amo ,&nbsp;B. Mataix-Albert ,&nbsp;M. Arias-Alcalá ,&nbsp;J. García-Montesinos-Gutiérrez ,&nbsp;C. Rocha-de-Lossada ,&nbsp;R. Villalba-Montoro ,&nbsp;M.S. Díaz-Gallardo ,&nbsp;N. Cuende ,&nbsp;A. Álvarez-Márquez","doi":"10.1016/j.oftal.2024.05.002","DOIUrl":"10.1016/j.oftal.2024.05.002","url":null,"abstract":"<div><h3>Objectives</h3><p>To show donation data, number of keratoplasties and the changes in transplant indications and techniques that occurred in Andalusia in the period from 2013 to 2022.</p></div><div><h3>Materials and methods</h3><p>The present work is a retrospective and descriptive study that included all keratoplasties performed between January 2013 and December 2022 in Andalusia, as well as the evolution of the cornea donation and transplant activity of the public and private hospitals pertaining to the waiting list management system of the Public Health System of Andalusia. Transplants performed in private centers with corneas from outside Andalusia were excluded.</p></div><div><h3>Results</h3><p>Cornea donation activity in Andalusia in the decade 2013-2022 has experienced a growth of more than 126%, while overall transplant activity has increased by 157% in public hospitals. Penetrating keratoplasty has decreased from 83% in 2013 to 43% in 2022, while lamellar techniques have increased from 17% to 57% in this same period. Since 2018, more lamellar transplants are performed than penetrating transplants. Regarding indications, endothelial conditions already represent the first cause of transplantation. In 2022 alone, the public Andalusian Eye Banks evaluated 1,054 corneas and prepared 281 endothelial grafts.</p></div><div><h3>Conclusion</h3><p>In the decade from 2013 to 2022 in Andalusia there has been an increase in donation activity and the number of keratoplasties. The public Eye Banks implementation in this period has played a key role in the widespread adoption of lamellar keratoplasty techniques and has enabled the transition to perform a greater number of lamellar keratoplasties compared to penetrating keratoplasty.</p></div>","PeriodicalId":8348,"journal":{"name":"Archivos De La Sociedad Espanola De Oftalmologia","volume":"99 9","pages":"Pages 383-391"},"PeriodicalIF":0.0,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142098078","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Experiencia con el uso de bevacizumab intravítreo en el manejo de la retinopatía del prematuro tipo I en un país latinoamericano","authors":"","doi":"10.1016/j.oftal.2024.03.012","DOIUrl":"10.1016/j.oftal.2024.03.012","url":null,"abstract":"<div><p>In retinopathy of prematurity (ROP) type<!--> <!-->I, the use of intravitreal bevacizumab (IVB), which is an inhibitor of endothelial growth factor (VEGF), has become popular despite not being a therapy approved by regulatory agencies. However, IVB has shown positive effects in halting disease progression at lower costs compared to other anti-VEGF therapies (ranibizumab or aflibercept). In this report, we present the experience during the treatment with IVB of 102 Colombian children with ROP type<!--> <!-->I, with a success rate of 98% (100). Complications occurred in 3.9% (4). Finally, we conclude that a single dose of IVB is an effective therapy for the management of ROP type<!--> <!-->I, with a lower risk of complications and retreatment.</p></div>","PeriodicalId":8348,"journal":{"name":"Archivos De La Sociedad Espanola De Oftalmologia","volume":"99 9","pages":"Pages 400-403"},"PeriodicalIF":0.0,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140779726","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Características del desprendimiento de retina pseudofáquico y factores de riesgo de recidiva","authors":"","doi":"10.1016/j.oftal.2024.04.012","DOIUrl":"10.1016/j.oftal.2024.04.012","url":null,"abstract":"<div><h3>Background</h3><p>The present study was designed to gain knowledge about the prognostic factors and evolution of pseudophakic retinal detachment (PRD) and to analyse the main characteristics of PRD, such as the mean time to retinal detachment following cataract surgery, as well as the clinical factors associated with the risk of recurrence and worse anatomical and functional outcomes.</p></div><div><h3>Methods</h3><p>This was a retrospective monocentric study of 330 patients with PRD who underwent surgery between 2012 and 2020. All patients were pseudophakic and were referred for retinal detachment surgery at Donostia University Hospital (Terciary Hospital, Spain).</p></div><div><h3>Results</h3><p>The mean age of the patients at the time of phacoemulsification was 63.06<!--> <!-->±<!--> <!-->10.8 years, and 49.09% of them had moderate myopia (axial length [AL] [23.5-26.5<!--> <!-->mm]). In our series, macular detachment was evident in 69.09% (n<!--> <!-->=<!--> <!-->228) of the patients. The mean time that elapsed between phacoemulsification and PRD surgery was 4.04<!--> <!-->±<!--> <!-->4.17 years, which was reduced by half in the event of surgical complications (2.24<!--> <!-->±<!--> <!-->2.65). The rate of PRD was 28.79%. The anatomical results in terms of retinal reapplication were better with the combination of vitrectomy and scleral buckling (83.1% vs. 70.5%) (p<!--> <!-->=<!--> <!-->0,127) compared with vitrectomy. The variables associated with a higher risk of recurrence were male sex (hazard ratio [HR]: 1.75), macular detachment (HR: 2.00) and the presence of proliferative vitreoretinopathy (PVR) (HR: 3.21).</p></div><div><h3>Conclusions</h3><p>PRD usually occurs within 4<!--> <!-->years of phacoemulsification, although it may occur significantly earlier in the event of surgical complications. Macular involvement, PVR, and male sex are all associated with a higher risk of PRD recurrence.</p></div>","PeriodicalId":8348,"journal":{"name":"Archivos De La Sociedad Espanola De Oftalmologia","volume":"99 9","pages":"Pages 365-372"},"PeriodicalIF":0.0,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141280295","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Formación en cirugía de cataratas en España: análisis de resultados de una encuesta del European Board of Ophthalmology en una cohorte española","authors":"","doi":"10.1016/j.oftal.2024.05.001","DOIUrl":"10.1016/j.oftal.2024.05.001","url":null,"abstract":"<div><h3>Introduction</h3><p>A survey conducted by the European Board of Ophthalmology (EBO) revealed significant differences in the surgical training of the ophthalmology residents in Europe, including a disparity between the sexes and a variation in the experience on cataract surgery (CC) between them. This study is about the Spanish sub-cohort of the survey, and its objective is to present and analyse the peculiarities of ophthalmology training in Spain within the European context, as well as discussing ways to harmonise and improve that training throughout the EU.</p></div><div><h3>Methods</h3><p>We analyse data of the Spanish participants in the EBO exams, defining subgroups by the Autonomous Communities existing in Spain.</p></div><div><h3>Results</h3><p>93 of 135 requested participants (68.9%) responded. A 60.2% passed the EBO exam between 2021-2022, being mostly women (65.59%) aged 31 years old on average. The 91.4% were right-handed, coming from 13 of the 17 Spanish autonomous communities, although mostly from the Community of Valencia, Madrid and Catalonia. Respectively, 16.1%, 3.2% and 8.7% of the respondents said they have completed 10 or more training sessions on animal eyes, synthetic eyes and through the virtual reality simulator. This training was correlated with greater self-confidence in the management of a posterior capsular tear during surgery (p 0.025). All respondents manifested to have already performed stages of the CC. The average number of operations reported was 181.6 with regional disparities. A significant difference is observed between the sexes against women (-28.3%, p 0.03).</p></div><div><h3>Discussion</h3><p>Ophthalmologists in Spain, much more than other European countries, have greater opportunities for surgical training, with surgical procedures during the residency, that nearly triples those made by the others. Spanish women refer, like their European colleagues, to be in disadvantage in learning opportunities about cataract surgery. The Simulation Based Medical Education (SBME) allows to respond to the training deficit and complements the training on the patient. Although we demonstrate a significant correlation between the number of procedures carried out and self-confidence to operate simple cases, the SBME would be a complementary tool in self-confidence in front of a complication like capsular rupture.</p></div><div><h3>Conclusion</h3><p>Spain massively adopts the model named by us “surgery for all”, despite the underrepresentation of women in this area, emphasising a need for cultural change that the SBME could facilitate.</p></div>","PeriodicalId":8348,"journal":{"name":"Archivos De La Sociedad Espanola De Oftalmologia","volume":"99 9","pages":"Pages 373-382"},"PeriodicalIF":0.0,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S0365669124000868/pdfft?md5=b80b4a89d9e069155fad60ac12a01f87&pid=1-s2.0-S0365669124000868-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141276808","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}